Dare Bioscience, Inc. Other Receivables, Net, Current
Dare Bioscience, Inc. (DARE) had Other Receivables, Net, Current of $573.06 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2026-03-26
- 2025-12-31: Other Receivables, Net, Current $573.06K.
- 2025-09-30: Other Receivables, Net, Current $369.16K.
- 2025-06-30: Other Receivables, Net, Current $188.12K.
- 2025-03-31: Other Receivables, Net, Current $105.23K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2025-12-31 | $573.06K 10-K · filed 2026-03-26 |
| 2025-09-30 | $369.16K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $188.12K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $105.23K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $229.98K 10-K · filed 2026-03-26 |
| 2024-09-30 | $518.89K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $902.17K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.39M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $949.21K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.13M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $572.47K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.40M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.70M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.29M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.14M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.73M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.15M 10-K · filed 2023-03-30 |
| 2021-09-30 | $156.25K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.96M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $301.83K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $460.17K 10-K · filed 2022-03-31 |
| 2020-09-30 | $213.56K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $177.13K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $429.72K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $555.21K 10-K · filed 2021-03-30 |
| 2019-09-30 | $37.84K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $493.02K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $166.71K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $31.04K 10-K · filed 2020-03-27 |
| 2018-09-30 | $80.28K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $24.64K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $28.89K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $284.21K 10-K · filed 2019-04-01 |
| 2017-09-30 | $710.69K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |